|
PL218749B1
(pl)
*
|
2002-02-14 |
2015-01-30 |
Pharmacia Corp |
Pochodna pirydynonu oraz jej zastosowanie do wytwarzania leku
|
|
CN101404986B
(zh)
*
|
2002-05-17 |
2011-09-28 |
赛奎拉公司 |
用于诊断和治疗感染性疾病的组合物和制药方法
|
|
US7456222B2
(en)
*
|
2002-05-17 |
2008-11-25 |
Sequella, Inc. |
Anti tubercular drug: compositions and methods
|
|
US20040033986A1
(en)
*
|
2002-05-17 |
2004-02-19 |
Protopopova Marina Nikolaevna |
Anti tubercular drug: compositions and methods
|
|
EP1405849A1
(en)
*
|
2002-10-04 |
2004-04-07 |
Corning Incorporated |
Halogenated styrene compounds and low-absorption-loss polymers obtainable therefrom
|
|
CL2004002050A1
(es)
*
|
2003-08-13 |
2005-06-03 |
Pharmacia Corp Sa Organizada B |
Compuestos derivados de piridinonas sustituidas; su uso en el tratamiento de afecciones causadas o exacerbadas por actividad p38 map kinasa y/o tnf no regulada, tales como inflamaciones, tumores, sida y otros.
|
|
US7884097B2
(en)
*
|
2003-09-05 |
2011-02-08 |
Sequella, Inc. |
Methods and compositions comprising diamines as new anti-tubercular therapeutics
|
|
JP4614884B2
(ja)
*
|
2003-11-14 |
2011-01-19 |
シャンハイ ゲノミックス インク |
ピリドンの誘導体とその使用
|
|
JP4869075B2
(ja)
*
|
2003-11-19 |
2012-02-01 |
アレイ バイオファーマ、インコーポレイテッド |
Ｍｅｋの複素環阻害剤及びその使用方法
|
|
HRP20100675T1
(hr)
|
2003-12-23 |
2011-01-31 |
Astex Therapeutics Limited |
Derivati pirazola kao modulatori protein kinaze
|
|
JPWO2005085200A1
(ja)
*
|
2004-03-05 |
2008-01-17 |
萬有製薬株式会社 |
ピリドン誘導体
|
|
JPWO2005105743A1
(ja)
*
|
2004-04-28 |
2008-03-13 |
小野薬品工業株式会社 |
含窒素複素環化合物およびその医薬用途
|
|
TWI355380B
(en)
*
|
2004-05-27 |
2012-01-01 |
Nihon Nohyaku Co Ltd |
Substituted pyrazinecarboxanilide derivatives or s
|
|
JP4853759B2
(ja)
*
|
2004-05-27 |
2012-01-11 |
日本農薬株式会社 |
置換ピラジンカルボン酸アニリド誘導体又はその塩類、その中間体及び農園芸用薬剤並びにその使用方法
|
|
PL1778686T3
(pl)
|
2004-08-12 |
2009-04-30 |
Pfizer |
Pochodne triazolopirydynylosulfanylowe jako inhibitory kinazy MAP P38
|
|
GB0420722D0
(en)
*
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
EP1802590A1
(en)
*
|
2004-10-13 |
2007-07-04 |
Pharmacia & Upjohn Company LLC |
Substituted n-alkylpyrimidinones
|
|
JP4973191B2
(ja)
*
|
2004-11-10 |
2012-07-11 |
小野薬品工業株式会社 |
含窒素複素環化合物およびその医薬用途
|
|
US20070293544A1
(en)
*
|
2004-11-24 |
2007-12-20 |
Ulrich Abel |
Novel 4-Arylamino Pyridone Derivatives as Mek Inhibitors for the Treatment of Hyper-Proliferative Disorders
|
|
BRPI0516383A
(pt)
|
2004-12-21 |
2008-09-02 |
Serono Lab |
derivados cìclicos de sulfonil amino e o uso dos mesmos
|
|
UA86862C2
(en)
|
2005-01-31 |
2009-05-25 |
Лаборатуар Сероно С.А. |
N-hydroxyamide derivatives and use thereof
|
|
PT1928454E
(pt)
*
|
2005-05-10 |
2014-12-04 |
Intermune Inc |
Derivativos da piridona para modulação do sistema de proteína quinase ativada pelo stress
|
|
EP1902032A1
(en)
|
2005-06-22 |
2008-03-26 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
|
US8541461B2
(en)
|
2005-06-23 |
2013-09-24 |
Astex Therapeutics Limited |
Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators
|
|
TW200740755A
(en)
*
|
2005-07-13 |
2007-11-01 |
Bayer Cropscience Sa |
Dihalogenation of N,O-disubstituted hydroxypyridones and their uses
|
|
EP1916239A4
(en)
|
2005-08-10 |
2009-10-21 |
Banyu Pharma Co Ltd |
PYRIDOLVERBINDUNG
|
|
JPWO2007024004A1
(ja)
|
2005-08-24 |
2009-03-05 |
萬有製薬株式会社 |
フェニルピリドン誘導体
|
|
ATE528302T1
(de)
|
2005-08-29 |
2011-10-15 |
Vertex Pharma |
3,5-disubstituierte pyrid-2-one, die als hemmer der tec-familie von nicht-rezeptor tyrosin- kinasen nützlich sind
|
|
AU2006285145A1
(en)
*
|
2005-08-29 |
2007-03-08 |
Vertex Pharmaceuticals Incorporated |
3,5-disubstituted pyrid-2-ones useful as inhibitors of Tec family of non-.receptor tyrosine kinases
|
|
WO2007027594A1
(en)
|
2005-08-29 |
2007-03-08 |
Vertex Pharmaceuticals Incorporated |
3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
|
|
WO2007025991A2
(en)
|
2005-09-01 |
2007-03-08 |
Ares Trading S.A. |
Treatment of optic neuritis
|
|
EP1939194A4
(en)
|
2005-09-07 |
2010-12-08 |
Banyu Pharma Co Ltd |
BICYCLIC AROMATIC SUBSTITUTED PYRIDONE DERIVATIVE
|
|
US7973060B2
(en)
*
|
2005-10-13 |
2011-07-05 |
Crystalgenomics, Inc. |
Fab I inhibitor and process for preparing same
|
|
TWI417095B
(zh)
|
2006-03-15 |
2013-12-01 |
Janssen Pharmaceuticals Inc |
１，４-二取代之３-氰基-吡啶酮衍生物及其作為ｍＧｌｕＲ２-受體之正向異位性調節劑之用途
|
|
US7718830B2
(en)
|
2006-04-24 |
2010-05-18 |
Allergan, Inc. |
Abnormal cannabidiols as agents for lowering intraocular pressure
|
|
US7618966B2
(en)
|
2006-04-24 |
2009-11-17 |
Allergan, Inc. |
Abnormal Cannabidiols as agents for lowering intraocular pressure
|
|
AU2007244978B2
(en)
*
|
2006-04-24 |
2013-05-30 |
Allergan, Inc. |
Abnormal Cannabidiols as agents for lowering intraocular pressure
|
|
UY30378A1
(es)
*
|
2006-06-02 |
2008-01-02 |
Janssen Pharmaceutica Nv |
Nuevos derivados de piridinona n-aril y n-heteroaril sustituidos para usar en enfermedades mediadas por mch-1
|
|
PT2029572E
(pt)
*
|
2006-06-05 |
2011-02-09 |
Novartis Ag |
Compostos orgânicos
|
|
CA2656535C
(en)
*
|
2006-07-14 |
2011-08-23 |
Amgen Inc. |
Alkyne-substituted pyridone compounds and methods of use
|
|
RU2453543C2
(ru)
|
2006-08-25 |
2012-06-20 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Новые производные пиридона, обладающие антагонистической активностью в отношении mch, и лекарственные средства, включающие такие соединения
|
|
WO2008041090A1
(en)
*
|
2006-10-06 |
2008-04-10 |
Pfizer Limited |
Malanin concentrating hormone receptor-1 antagonist pyridinones
|
|
WO2008071646A1
(en)
|
2006-12-11 |
2008-06-19 |
Boehringer Ingelheim International Gmbh |
New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds
|
|
WO2008072079A2
(en)
*
|
2006-12-13 |
2008-06-19 |
Pfizer Products Inc. |
Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2h)-yl)-n,4-dimethylbenzamide
|
|
US9562019B2
(en)
*
|
2006-12-21 |
2017-02-07 |
Sloan-Kettering Institute For Cancer Research |
Substituted pyridazines as EGFR and/or KRAS inhibitors
|
|
JP2010515745A
(ja)
*
|
2007-01-10 |
2010-05-13 |
アルバニー モレキュラー リサーチ， インコーポレイテッド |
５−フロピリジノン置換インダゾール
|
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
|
GB0704932D0
(en)
|
2007-03-14 |
2007-04-25 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
|
KR101767849B1
(ko)
|
2007-06-20 |
2017-08-11 |
오스펙스 파마슈티칼스, 인코포레이티드 |
섬유증 저해제로서의 치환된 ｎ-아릴 피리디논
|
|
US7928230B2
(en)
*
|
2007-07-17 |
2011-04-19 |
Bristol-Myers Squibb Company |
Method for modulating GPR119 G protein-coupled receptor and selected compounds
|
|
AU2008297877C1
(en)
|
2007-09-14 |
2013-11-07 |
Addex Pharma S.A. |
1,3-disubstituted-4-phenyl-1 H-pyridin-2-ones
|
|
CN101848893B
(zh)
|
2007-09-14 |
2012-06-06 |
奥梅-杨森制药有限公司 |
1,3-二取代的4-(芳基-x-苯基)-1h-吡啶-2-酮
|
|
EP2203439B1
(en)
|
2007-09-14 |
2011-01-26 |
Ortho-McNeil-Janssen Pharmaceuticals, Inc. |
1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-ý1, 4'¨bipyridinyl-2'-ones
|
|
JP5592265B2
(ja)
|
2007-11-01 |
2014-09-17 |
アキュセラ インコーポレイテッド |
眼の疾患及び障害治療用のアミン誘導体化合物
|
|
CN101861316B
(zh)
|
2007-11-14 |
2013-08-21 |
奥梅-杨森制药有限公司 |
咪唑并[1,2-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
|
|
EP2222661B1
(en)
*
|
2007-11-20 |
2016-04-20 |
Merck Sharp & Dohme Corp. |
Non-nucleoside reverse transcriptase inhibitors
|
|
WO2009136965A1
(en)
*
|
2008-05-06 |
2009-11-12 |
Sequella, Inc. |
Compositions and methods comprising capuramycin analogues
|
|
US8304413B2
(en)
|
2008-06-03 |
2012-11-06 |
Intermune, Inc. |
Compounds and methods for treating inflammatory and fibrotic disorders
|
|
MX2011002042A
(es)
|
2008-09-02 |
2011-06-20 |
Ortho Mcneil Janssen Pharm |
Derivados de 3-azabiciclo[3.1.o]hexilo como moduladores de los receptores del glutamato metabotropico.
|
|
EA201100311A1
(ru)
|
2008-09-11 |
2011-10-31 |
Пфайзер Инк. |
Амидные производные гетероарилов и их применение в качестве активаторов глюкокиназы
|
|
ES2466341T3
(es)
|
2008-10-16 |
2014-06-10 |
Janssen Pharmaceuticals, Inc. |
Derivados de indol y benzomorfolina como moduladores de receptores de glutamato metabotrópicos
|
|
WO2010060589A1
(en)
|
2008-11-28 |
2010-06-03 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
|
|
CA2748587A1
(en)
|
2009-01-20 |
2010-07-29 |
Pfizer Inc. |
Substituted pyrazinone amides
|
|
AU2010222589B2
(en)
|
2009-03-11 |
2012-08-16 |
Pfizer Inc. |
Benzofuranyl derivatives used as glucokinase inhibitors
|
|
EP2430022B1
(en)
|
2009-05-12 |
2013-11-20 |
Janssen Pharmaceuticals, Inc. |
1,2,4-Triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
|
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
JP5707390B2
(ja)
|
2009-05-12 |
2015-04-30 |
ジャンセン ファーマシューティカルズ， インコーポレイテッド |
１，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体の正のアロステリック調節因子としてのその使用
|
|
ES2536200T3
(es)
*
|
2009-05-25 |
2015-05-21 |
Central South University |
Preparación de compuestos de tipo 1-(bencilo sustituido)-5-trifluorometil-2-(1H)piridona, sales de estos y sus aplicaciones
|
|
US8426407B2
(en)
|
2009-05-25 |
2013-04-23 |
Central South University |
Preparation of 1-(substituted aryl)-5-trifluoromethyl-2-(1H)pyridone compounds and salts thereof and their applications
|
|
US20110021570A1
(en)
|
2009-07-23 |
2011-01-27 |
Nancy-Ellen Haynes |
Pyridone glucokinase activators
|
|
CN101973936B
(zh)
*
|
2010-09-28 |
2012-02-08 |
太原理工大学 |
一种吡啶酮衍生物的制备方法
|
|
EP2661435B1
(en)
|
2010-11-08 |
2015-08-19 |
Janssen Pharmaceuticals, Inc. |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
|
WO2012062750A1
(en)
|
2010-11-08 |
2012-05-18 |
Janssen Pharmaceuticals, Inc. |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
|
CA2814998C
(en)
|
2010-11-08 |
2019-10-29 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
US9359300B2
(en)
|
2010-12-06 |
2016-06-07 |
Confluence Life Sciences, Inc. |
Methyl/difluorophenyl-methoxy substituted pyridinone-pyridinyl compounds, methyl-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds, and methyl-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds
|
|
ES2873029T3
(es)
*
|
2010-12-06 |
2021-11-03 |
Aclaris Therapeutics Inc |
Compuestos de piridinona-piridinilo sustituidos
|
|
WO2012078674A1
(en)
|
2010-12-06 |
2012-06-14 |
Confluence Life Sciences, Inc. |
Substituted indole/indazole-pyrimidinyl compounds
|
|
US8563558B2
(en)
|
2010-12-06 |
2013-10-22 |
Confluence Life Sciences, Inc. |
Substituted pyridine urea compounds
|
|
AP3336A
(en)
*
|
2011-03-07 |
2015-07-31 |
Pfizer |
Fluoro-pyridinone derivatives useful as antibacterial agents
|
|
AU2012225611B2
(en)
|
2011-03-08 |
2016-09-15 |
Auspex Pharmaceuticals, Inc. |
Substituted N-Aryl pyridinones
|
|
MX2014002298A
(es)
*
|
2011-08-29 |
2014-07-22 |
Ptc Therapeutics Inc |
Compuestos antibacterianos y metodos para su uso.
|
|
JP2014525452A
(ja)
*
|
2011-08-29 |
2014-09-29 |
ピーティーシー セラピューティクス， インコーポレイテッド |
抗菌化合物および使用方法
|
|
EP2768826A1
(de)
*
|
2011-10-17 |
2014-08-27 |
Bayer Intellectual Property GmbH |
Substituierte oxadiazolylpyridinone und - pyridazinone als hif - hemmer
|
|
BR112014012288A2
(pt)
|
2011-11-22 |
2017-05-23 |
Intermune Inc |
métodos para diagnosticar e tratar fibrose pulmonar idiopática
|
|
WO2013086208A1
(en)
*
|
2011-12-06 |
2013-06-13 |
Confluence Life Sciences, Inc. |
Substituted pyrimidinone-phenyl-pyrimidinyl compounds
|
|
JP6137193B2
(ja)
|
2011-12-21 |
2017-05-31 |
小野薬品工業株式会社 |
第ＸＩａ因子阻害剤としての新規ピリジノンおよびピリミジノン誘導体
|
|
EP2802571A1
(en)
*
|
2012-01-12 |
2014-11-19 |
Takeda Pharmaceutical Company Limited |
Benzimidazole derivatives as mch receptor antagonists
|
|
PL2820009T3
(pl)
*
|
2012-03-01 |
2018-09-28 |
Array Biopharma, Inc. |
Inhibitory kinaz serynowo/treoninowych
|
|
CN103288719A
(zh)
*
|
2012-03-05 |
2013-09-11 |
苏州欧凯医药技术有限公司 |
非核甘艾滋病毒抑制物-吡啶酮类先导体的合成
|
|
JP5924984B2
(ja)
*
|
2012-03-06 |
2016-05-25 |
国立大学法人東京農工大学 |
トリフルオロメチルピリジノン化合物およびその製造方法
|
|
MX2015000830A
(es)
|
2012-07-18 |
2015-10-26 |
Sunshine Lake Pharma Co Ltd |
Derivados heterociclicos nitrogenosos y su aplicacion en farmacos.
|
|
US9018380B2
(en)
|
2012-08-24 |
2015-04-28 |
Boar of Regents, The University of Texas System |
Heterocyclic modulators of HIF activity for treatment of disease
|
|
EP2888256A4
(en)
*
|
2012-08-24 |
2016-02-17 |
Univ Texas |
HETEROCYCLIC HIF ACTIVITY MODULATORS FOR THE TREATMENT OF DISEASES
|
|
AR092742A1
(es)
|
2012-10-02 |
2015-04-29 |
Intermune Inc |
Piridinonas antifibroticas
|
|
ES2614281T3
(es)
|
2012-12-13 |
2017-05-30 |
Novartis Ag |
Derivados de piridona y derivados de los mismos en el tratamiento de tuberculosis
|
|
PL2953931T3
(pl)
*
|
2013-01-31 |
2017-09-29 |
Vertex Pharmaceuticals Incorporated |
Pirydonoamidy jako modulatory kanałów sodowych
|
|
WO2014181213A1
(en)
|
2013-05-10 |
2014-11-13 |
Pfizer Inc. |
Crystalline form of (sa)-(-)-3-(3-bromo-4-((2,4-difluorobenzyl)oxy)-6-methyl-2-oxopyridin-1 (2h)-yl)-n,4-dimethylbenzamide
|
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
|
US9115089B2
(en)
|
2013-06-07 |
2015-08-25 |
Confluence Life Sciences, Inc. |
Methyl/fluoro-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds and fluoro-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds
|
|
CA2917490A1
(en)
|
2013-07-09 |
2015-01-15 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
|
SMT201800521T1
(it)
|
2013-12-13 |
2018-11-09 |
Vertex Pharma |
Profarmaci di piridonammidi utili come modulatori di canali del sodio
|
|
AU2015208233B2
(en)
|
2014-01-21 |
2019-08-29 |
Janssen Pharmaceutica Nv |
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
|
|
ME03518B
(me)
|
2014-01-21 |
2020-04-20 |
Janssen Pharmaceutica Nv |
Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena
|
|
DK3110420T3
(da)
|
2014-02-25 |
2019-05-13 |
Board Of Regents Univ Of Texas System |
Salte af heterocykliske modulatorer af hif-aktivitet til behandling af sygdomme
|
|
KR102373700B1
(ko)
|
2014-04-02 |
2022-03-11 |
인터뮨, 인크. |
항섬유성 피리디논
|
|
PL3174852T3
(pl)
*
|
2014-07-30 |
2018-11-30 |
ABAC Therapeutics, S.L. |
Arylohydrazydy zawierające ugrupowanie 2-pirydonu jako selektywne środki przeciwbakteryjne
|
|
JP6610562B2
(ja)
|
2014-12-10 |
2019-11-27 |
小野薬品工業株式会社 |
ジヒドロインドリジノン誘導体
|
|
EA034912B1
(ru)
*
|
2015-06-03 |
2020-04-06 |
Бристол-Маерс Сквибб Компани |
4-гидрокси-3-(гетероарил)пиридин-2-оновые агонисты apj для применения в лечении сердечно-сосудистых заболеваний
|
|
CN105153027A
(zh)
*
|
2015-07-21 |
2015-12-16 |
东华大学 |
一种3-氰基-4-羟基-2-吡啶酮类化合物及其制备和应用
|
|
CN106466318B
(zh)
*
|
2015-08-21 |
2019-01-01 |
中南大学 |
1-杂环取代苄基吡啶酮类化合物在制备治疗糖尿病肾病药物中的应用
|
|
WO2017151409A1
(en)
|
2016-02-29 |
2017-09-08 |
University Of Florida Research Foundation, Incorporated |
Chemotherapeutic methods
|
|
WO2018213426A1
(en)
|
2017-05-16 |
2018-11-22 |
Vertex Pharmaceuticals Incorporated |
Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels
|
|
KR102236356B1
(ko)
|
2017-11-24 |
2021-04-05 |
주식회사 종근당 |
루푸스의 예방 또는 치료를 위한 조성물
|
|
JP2021512935A
(ja)
|
2018-02-12 |
2021-05-20 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
疼痛を処置する方法
|
|
KR20190099952A
(ko)
*
|
2018-02-20 |
2019-08-28 |
주식회사 종근당 |
포도막염의 예방 또는 치료를 위한 조성물
|
|
US12351556B2
(en)
*
|
2019-10-04 |
2025-07-08 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Pyridin-2(1H)one derivatives, their preparation and their use for the treatment of pain
|
|
PH12022551379A1
(en)
|
2019-12-06 |
2023-05-03 |
Vertex Pharma |
Substituted tetrahydrofurans as modulators of sodium channels
|
|
GB201918413D0
(en)
*
|
2019-12-13 |
2020-01-29 |
Z Factor Ltd |
Compounds and their use for the treatment of alpha1-antitrypsin deficiency
|
|
MX2022011755A
(es)
|
2020-03-27 |
2022-11-16 |
Aclaris Therapeutics Inc |
Proceso, composiciones y formas cristalinas de compuestos de piridinona-piridinilo sustituidos.
|
|
CN112552232B
(zh)
*
|
2020-12-16 |
2022-11-25 |
浙江工业大学 |
一种吡啶酮六位炔胺修饰衍生物及其制备方法与应用
|
|
KR20230152692A
(ko)
|
2021-02-02 |
2023-11-03 |
리미널 바이오사이언시스 리미티드 |
Gpr84 길항제 및 이의 용도
|
|
PE20240144A1
(es)
*
|
2021-03-31 |
2024-02-01 |
Xinthera Inc |
Inhibidores de mk2 y usos de estos
|
|
DK4347031T3
(da)
|
2021-06-04 |
2025-12-01 |
Vertex Pharma |
N-(hydroxyalkyl-(hetero)aryl)-tetrahydrofuran-carboxamider som modulatorer af natriumkanaler
|
|
US11685719B2
(en)
|
2021-07-09 |
2023-06-27 |
Xinthera, Inc. |
Pyridinone MK2 inhibitors and uses thereof
|
|
WO2023134765A1
(zh)
*
|
2022-01-14 |
2023-07-20 |
上海翰森生物医药科技有限公司 |
含五元环类衍生物、其制备方法和应用
|
|
WO2024022412A1
(zh)
*
|
2022-07-28 |
2024-02-01 |
深圳信立泰药业股份有限公司 |
一种式(i)所示的三联吡啶二酮化合物晶型及其制备方法与应用
|